Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-338-7 | CAS number: 3069-40-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 08.01.1990 to 22.02.1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Trimethoxyoctylsilane
- EC Number:
- 221-338-7
- EC Name:
- Trimethoxyoctylsilane
- Cas Number:
- 3069-40-7
- Molecular formula:
- C11H26O3Si
- IUPAC Name:
- trimethoxyoctylsilane
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Wiga, Sulzfeld, FRG.
- Age at study initiation: 7-11 weeks
- Weight at study initiation: 260-170 g
- Fasting period before study: No data
- Housing: In between exposures in suspended stainless steel cages (5 animals/cage), and during exposure housed individually
- Diet (e.g. ad libitum): Ad libitum (except during exposure when food was not available)
- Water (e.g. ad libitum): Ad libitum (except during exposure when food was not available)
- Acclimation period: From arrival to start of study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ±3
- Humidity (%): 30-70
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 08.01.1990 to 22.02.1990
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- other: whole body for first part of study and nose-only for second part.
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Whole body: horizontally placed, all glass cylinder, separated from other animals by a perforated stainless steel plates. Ports in the middle and at the end of the cylinder allowed sampling of the test substance. Nose-only: nose-only inhalation chamber type 8132 P2. Only the nose of the rats was protruding into the exposure chamber.
- Source and rate of air: No information on source. Rate for whole body exposure 10 l/min, for nose
- System of generating particulates/aerosols: the test atmosphere was generated by bubbling the total flow of heated air through the heated test substance. In this way the air flow became saturated with test substance. Since the concentration obtained in this way was not sufficiently high, test atmospheres for the other concentrations were generated in a different way. A sample of test substance was poured into a flask. A roller pump passed metered amounts of the test substance from the flask to a Lee 150H nebuliser connected at the top of the chamber. The air volume through the nebuliser was at maximum. The generated aerosol was diluted with clean air from the compressed air system. The aerosol was directed downwards through the mixing chambers towards the noses of the animals.
- Method of particle size determination: 11-stage cascade impactor.
- Treatment of exhaust air: Passed out from the bottom of the chamber - no further details .
- Temperature, humidity, pressure in air chamber: Whole body: 19.8 ±0.3oC, 80 ±4%, slight negative pressure. Nose-only: 18.2 oC, 69%, slightly positive pressure.
TEST ATMOSPHERE
- Brief description of analytical method used: The actual mass concentration of the test substance in the test atmosphere was determined each hour by means of gas chromatography.
- Samples taken from breathing zone: no data - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- Mean actual concentrations: 0.9, 2.36, 2.53 and 6.2 g/m3.
Corresponding nominal concentrations: 3.5, 9.8, 15.4 and 27.6 g/m3. - No. of animals per sex per dose:
- Five
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Rats were visually inspected during the exposure period, and once daily during the observation period. Body weights were recorded just prior to exposure and at days 7 and 14.
- Necropsy of survivors performed: yes, at the end of the observation period, all surviving rats were killed and examined for gross pathological changes. - Statistics:
- The LC50 was calculated using Probit analysis.
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 7.5 other: g/m3
- Based on:
- test mat.
- 95% CL:
- >= 4.3 - <= 29.7
- Exp. duration:
- 4 h
- Key result
- Sex:
- female
- Dose descriptor:
- LC50
- Effect level:
- 1.9 other: g/m3
- Based on:
- test mat.
- 95% CL:
- >= 1 - <= 3.1
- Exp. duration:
- 4 h
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 3.9 other: g/m3
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- See Table 1. All deaths occurred within days 1-3.
- Clinical signs:
- other: During exposure to 0.9 g/m3 animals showed hunched appearance, piloerection and mostly closed eyes. Breathing patterns were superficial and irregular during the first hour of exposure. Then, breathing patterns became more regular concomitant with a decrea
- Body weight:
- All four surviving rats exposed to 6.2 g/m3 showed severe body weight reduction seven days after exposure. However, body weight gain was observed 14 days after exposure in three out of four rats. Exposure to 0.9 g/m3 resulted in body weight gain reduction in male rats 14 days after exposure, and in decreased body weight or reduced body weight gain in female rats 7 and 14 days after exposure. Body weight gain of the other survivors exposed to 2.53 or 2.36 g/m3 was generally not affected by exposure.
- Gross pathology:
- At autopsy, dark-red discoloured, and sometimes swollen or darkly spotted, and/or edematous lungs were found in animals that died, or were killed in extremis after exposure to 6.2 g/m3. Furthermore, grey-white spots were observed on the lung lobes of three female rats. Exposure to 2.53 g/m3 revealed rusty-brown discoloured lungs. Red discoloured lungs were found in rats exposed to 2.36 g/m3. In the other rats that were killed in extremis no abnormalities were observed. In all surviving rats autopsied at the end of the 14-day observation period, no abnormalities were found, except for spotted lungs in one male exposed to 6.2 g/m3.
- Other findings:
- None
Any other information on results incl. tables
The 50% accumulation point for all four distributions was around 2.4 µm. All distributions showed a similar pattern: about 60% (exposure to 6.2 g/m3) to 89% (exposure to 0.9 g/m3) of the particles were between 1.8 and 3.4 µm in diameter.
Table 1 Summary of concentrations and mortality data
Group | Concentration (g/m3) | Mortality | ||
Actual | Nominal | Males (number tested/deaths) | Female (number tested/deaths) | |
A | 0.9 ± 0.32 | 3.5 | 5/0 | 5/0 |
B | 6.2 ± 0.6 | 27.6 | 5/1 | 5/5 |
D | 2.53 ± 0.64 | 15.4 | 5/0 | 5/4 |
E | 2.36 0.31 | 9.8 | 5/1 | 5/3 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- In an inhalation study conducted according to OECD Test Guideline 403 and in compliance with GLP (reliability score 1) the LC50 for trimethoxyoctylsilane was 7.5 and 1.9 g/m3 for males and females, respectively. The combined LC50 was 3.9 g/m3. Clinical effects included reduced body weights, slow breathing, piloerection and signs of ataxia.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
